- ►prsjournal.com G Weigert, S Michels, S Sacu, A Varga, F … - British Journal of Ophthalmology, 2008 - bjo.bmj.com Results: In the bevacizumab-treated group mean visual acuity (VA) improved to a
2.2 line gain at 6 months follow-up. Eyes treated in the PDT plus IVTA group had
a stable mean VA at month 6 compared with baseline. There was a ... Cited by 27 - Related articles - BL Direct - All 7 versions
J Baath, AL Ells, A Crichton, A Kherani, RG … - Journal of Ocular Pharmacology and Therapeutics, 2007 - liebertonline.com Background: There is currently a widespread use of intravitreal triamcinolone
acetonide (IVTA) for age-related macular degeneration, diabetic macular edema,
cystoid macular edema secondary to retinal vein occlusions, and uveitis. ... Cited by 11 - Related articles - BL Direct - All 4 versions
CM Jermak, JT Dellacroce, J Heffez, GA … - Survey of Ophthalmology, 2007 - Elsevier Corticosteroids have been used to treat inflammatory conditions of the eye since
the 1950s and have been injected intraocularly since 1974. 95 The purpose of
this article is to outline the current use and highlight the ever-growing ... Cited by 9 - Related articles - All 4 versions
… PG NEHEMY, AP SCHACHAT, MB NEHEMY - Retina, 2008 - journals.lww.com Conclusions: A 4-mg IVTA injection was associated with SOH in 32.0% of treated
eyes. The risk of SOH was higher in eyes with previous glaucoma and higher
baseline IOP. Peak IOP after IVTA injection was lower in vitrectomized ... Cited by 7 - Related articles - BL Direct - All 4 versions
- ►nih.gov MD Conway - British Medical Journal, 2006 - bjo.bmj.com A more predictive test was reported by Bhavan et al and in our other studies
where a test dose of 400 μg of IVTA provoked an elevated IOP in 8–15% of
non-glaucomatous eyes within 1 week following IVTA and 33% of eyes with pre- ... Cited by 4 - Related articles - BL Direct - All 8 versions
L Im, R Allingham, I Singh, S Stinnett, S Fekrat - Journal of Glaucoma, 2008 - journals.lww.com Skip Navigation Links Home > March 2008 - Volume 17 - Issue 2 > A Prospective
Study of Early Intraocular Pressure Changes Af... ... There are no proprietary
commercial interests, sponsors, or grants for this study. All support was ... Cited by 2 - Related articles - BL Direct - All 3 versions
- ►aravind.org [PDF] D Shukla, N Vidhya, NM Prasad, R … - American Journal of Ophthalmology, 2007 - Elsevier A total of 164 outpatients (164 eyes) aged 21 to 80 years (mean, 56.8 years),
presenting with exudative age-related maculopathy (51) or macular edema of
various etiologies (113), received IVTA (4 mg/0.1 ml). The primary outcome ... Cited by 3 - Related articles - All 14 versions
SM Gerzenstein, MT Pletcher, ACL Cervino, … - Ophthalmic Genetics, 2008 - informahealthcare.com Background: Elevation of intraocular pressure (IOP) following injection of
intravitreal triamcinolone acetonide (IVTA) is an important clinical problem.
The etiology of the steroid response is poorly understood, although a ... Cited by 2 - Related articles - All 5 versions
